Coversyl: Effective Blood Pressure Control for Cardiovascular Protection
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.61 | $48.23 (0%) | 🛒 Add to cart |
| 60 | $1.41 | $96.46 $84.40 (12%) | 🛒 Add to cart |
| 90 | $1.21 | $144.69 $108.52 (25%) | 🛒 Add to cart |
| 120 | $1.16 | $192.92 $138.66 (28%) | 🛒 Add to cart |
| 180 | $1.11 | $289.38 $198.95 (31%) | 🛒 Add to cart |
| 270 | $0.90 | $434.07 $244.16 (44%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $578.76 $289.38 (50%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.01 | $40.19 (0%) | 🛒 Add to cart |
| 30 | $1.71 | $60.29 $51.24 (15%) | 🛒 Add to cart |
| 60 | $1.51 | $120.57 $90.43 (25%) | 🛒 Add to cart |
| 90 | $1.34 | $180.86 $120.57 (33%) | 🛒 Add to cart |
| 120 | $1.21 | $241.15 $144.69 (40%) | 🛒 Add to cart |
| 180 | $1.16 | $361.72 $207.99 (42%) | 🛒 Add to cart |
| 270 | $1.11 | $542.59 $298.42 (45%) | 🛒 Add to cart |
| 360 | $1.00
Best per pill | $723.45 $361.72 (50%) | 🛒 Add to cart |
| Product dosage: 8mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $3.01 | $60.29 (0%) | 🛒 Add to cart |
| 30 | $2.81 | $90.43 $84.40 (7%) | 🛒 Add to cart |
| 60 | $2.61 | $180.86 $156.75 (13%) | 🛒 Add to cart |
| 90 | $2.41 | $271.29 $217.03 (20%) | 🛒 Add to cart |
| 120 | $2.21 | $361.72 $265.26 (27%) | 🛒 Add to cart |
| 180 | $2.01 | $542.59 $361.72 (33%) | 🛒 Add to cart |
| 270 | $1.71 | $813.88 $461.20 (43%) | 🛒 Add to cart |
| 360 | $1.51
Best per pill | $1085.17 $542.59 (50%) | 🛒 Add to cart |
Coversyl, containing the active ingredient perindopril, is an angiotensin-converting enzyme (ACE) inhibitor prescribed for the management of hypertension and certain heart conditions. It works by relaxing blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently. This medication is a cornerstone in preventive cardiology, aiding in reducing the risk of major cardiovascular events. Adherence to a prescribed regimen under medical supervision is crucial for achieving optimal therapeutic outcomes.
Features
- Active ingredient: Perindopril (as perindopril arginine or perindopril erbumine)
- Drug class: Angiotensin-converting enzyme (ACE) inhibitor
- Available in various tablet strengths (e.g., 2.5 mg, 5 mg, 10 mg)
- Once-daily oral administration for consistent 24-hour coverage
- Proven efficacy in clinical trials for blood pressure reduction
- May be used as monotherapy or in combination with other antihypertensives
Benefits
- Significantly lowers both systolic and diastolic blood pressure, reducing strain on the heart and arteries.
- Decreases the risk of heart attack, stroke, and other major adverse cardiac events in high-risk patients.
- Can improve survival and functional status in patients with chronic heart failure.
- Helps protect kidney function, particularly in hypertensive patients with diabetes.
- Contributes to the regression and prevention of left ventricular hypertrophy.
- Supports long-term cardiovascular health with a well-established safety profile.
Common use
Coversyl is primarily indicated for the treatment of essential hypertension. It is also used in the management of stable coronary artery disease to reduce the risk of cardiac events in patients with a history of myocardial infarction or revascularization. Additionally, it is approved for the treatment of symptomatic heart failure, usually as part of a broader therapeutic regimen. Its use is always based on a comprehensive cardiovascular assessment by a healthcare provider.
Dosage and direction
The dosage of Coversyl must be individualized based on the patient’s condition, renal function, and response to therapy. For hypertension, the usual starting dose is 4 mg once daily, which may be increased to 8 mg after at least four weeks if necessary. In elderly patients or those with renal impairment, a lower starting dose of 2 mg is recommended. Tablets should be taken orally, preferably at the same time each day, with or without food. It is often advised to take the dose in the morning to minimize potential nocturnal hypotension. Dosage adjustments should only be made under medical supervision.
Precautions
Before initiating Coversyl, assess renal function and electrolytes. Monitor blood pressure regularly, especially after dose adjustments. Use with caution in patients with renal artery stenosis, as ACE inhibitors can cause renal impairment. There is a risk of hyperkalemia; avoid potassium supplements or salt substitutes containing potassium unless recommended and monitored. May cause symptomatic hypotension, particularly in volume-depleted patients. Angioedema has been reported; discontinue immediately if signs occur. Not recommended during pregnancy due to potential fetal harm. Use in lactation only if clearly needed and with caution.
Contraindications
Coversyl is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy. It is also contraindicated in patients with hereditary or idiopathic angioedema. Do not use in combination with aliskiren in patients with diabetes or in patients with renal impairment (GFR < 60 mL/min/1.73 m²). Contraindicated during the second and third trimesters of pregnancy. Should not be administered to patients with hypersensitivity to perindopril or any other component of the formulation.
Possible side effect
Common side effects may include cough, dizziness, headache, fatigue, and gastrointestinal disturbances such as nausea or diarrhea. Less frequently, orthostatic hypotension, rash, taste disturbance, and hyperkalemia may occur. Rare but serious side effects include angioedema, neutropenia/agranulocytosis, renal impairment, and severe hypotension. Patients should report any persistent or severe symptoms to their healthcare provider promptly.
Drug interaction
Coversyl may interact with diuretics, potentiating the risk of hypotension. Concurrent use with potassium-sparing diuretics, potassium supplements, or salt substitutes may increase the risk of hyperkalemia. NSAIDs can reduce the antihypertensive effect and increase the risk of renal dysfunction. Use with lithium may increase lithium levels and toxicity. Dual blockade of the renin-angiotensin system (e.g., with ARBs or aliskiren) is not recommended due to increased risks of hypotension, hyperkalemia, and renal impairment. Always inform your physician of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose of Coversyl is missed, it should be taken as soon as remembered on the same day. If it is nearly time for the next dose, skip the missed dose and resume the usual dosing schedule. Do not take a double dose to make up for a missed one. Consistent daily intake is important for maintaining stable blood pressure control.
Overdose
Overdose of Coversyl may lead to severe hypotension, bradycardia, circulatory shock, electrolyte disturbances, and renal failure. Symptoms can include dizziness, weakness, and fainting. Management is supportive and may include volume expansion with intravenous fluids and vasopressors if necessary. Hemodialysis may be effective in removing perindopril. In case of suspected overdose, seek immediate medical attention or contact a poison control center.
Storage
Store Coversyl tablets at room temperature (15–30°C or 59–86°F), in a dry place, protected from light and moisture. Keep the medication in its original container, tightly closed, and out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper disposal of unused medication should follow local guidelines or through a medicine take-back program.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment decisions, and personalized recommendations. Do not initiate, adjust, or discontinue any medication without professional guidance. Individual responses to medication may vary.
Reviews
Clinical studies and meta-analyses consistently demonstrate the efficacy of perindopril (Coversyl) in reducing blood pressure and cardiovascular risk. It is regarded favorably in treatment guidelines for its once-daily dosing and protective benefits. Patient experiences often note effective control of hypertension with manageable side effects, though the persistent dry cough can be a drawback for some. Overall, it remains a trusted option in antihypertensive therapy under appropriate medical supervision.